These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8391355)

  • 21. HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women.
    Langley CL; Benga-De E; Critchlow CW; Ndoye I; Mbengue-Ly MD; Kuypers J; Woto-Gaye G; Mboup S; Bergeron C; Holmes KK; Kiviat NB
    AIDS; 1996 Apr; 10(4):413-7. PubMed ID: 8728046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia.
    Ho GY; Kadish AS; Burk RD; Basu J; Palan PR; Mikhail M; Romney SL
    Int J Cancer; 1998 Oct; 78(3):281-5. PubMed ID: 9766558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cervical intraepithelial neoplasia and human papillomavirus infection among Senegalese women seropositive for HIV-1 or HIV-2 or seronegative for HIV.
    Seck AC; Faye MA; Critchlow CW; Mbaye AD; Kuypers J; Woto-Gaye G; Langley C; De EB; Holmes KK; Kiviat NB
    Int J STD AIDS; 1994; 5(3):189-93. PubMed ID: 8061090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of human papillomavirus infection of the uterine cervix as determined by different detection methods in a low-risk community-based population.
    Zazove P; Reed BD; Gregoire L; Gorenflo DW; Lancaster WD; Ruffin MT; Hruszczyk J
    Arch Fam Med; 1993 Dec; 2(12):1250-8. PubMed ID: 8130906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study.
    Branca M; Costa S; Mariani L; Sesti F; Agarossi A; di Carlo A; Galati M; Benedetto A; Ciotti M; Giorgi C; Criscuolo A; Valieri M; Favalli C; Paba P; Santini D; Piccione E; Alderisio M; De Nuzzo M; di Bonito L; Syrjänen K
    Eur J Gynaecol Oncol; 2004; 25(6):689-98. PubMed ID: 15597844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of genital human papillomavirus among Lebanese women.
    Mroueh AM; Seoud MA; Kaspar HG; Zalloua PA
    Eur J Gynaecol Oncol; 2002; 23(5):429-32. PubMed ID: 12440818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.
    Schlecht NF; Kulaga S; Robitaille J; Ferreira S; Santos M; Miyamura RA; Duarte-Franco E; Rohan TE; Ferenczy A; Villa LL; Franco EL
    JAMA; 2001 Dec; 286(24):3106-14. PubMed ID: 11754676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
    Cox JT;
    Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.
    Flores Y; Shah K; Lazcano E; Hernández M; Bishai D; Ferris DG; Lörincz A; Hernández P; Salmerón J;
    Salud Publica Mex; 2002; 44(4):335-44. PubMed ID: 12216521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear.
    Arora R; Kumar A; Prusty BK; Kailash U; Batra S; Das BC
    Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):104-9. PubMed ID: 15950365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
    Ouh YT; Min KJ; Cho HW; Ki M; Oh JK; Shin SY; Hong JH; Lee JK
    J Gynecol Oncol; 2018 Jan; 29(1):e14. PubMed ID: 29185272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the human papillomavirus test and Papanicolaou smear as a second screening method for women with minor cytological abnormalities.
    Andersson S; Dillner L; Elfgren K; Mints M; Persson M; Rylander E
    Acta Obstet Gynecol Scand; 2005 Oct; 84(10):996-1000. PubMed ID: 16167918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invader human papillomavirus (HPV) type 16 and 18 assays as adjuncts to HPV screening of cervical papanicolaou smears with atypical squamous cells of undetermined significance.
    Wong AK; Chan RC; Nichols WS; Bose S
    Cancer; 2009 Feb; 115(4):823-32. PubMed ID: 19127558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
    Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Borgatta L; Buck H; Kramer L; Rubin R
    J Fam Pract; 1998 Feb; 46(2):125-34. PubMed ID: 9487318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of correlation factors for cervical intraepithelial neoplasia in married women in Beijing, China].
    Li CD; Zhang WY; Zhang SW; Wu MH; Wang JD
    Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(3):196-200. PubMed ID: 20356557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection and quantitation of HPV gene expression using real-time PCR.
    Seth R; Rippin J; Guo L; Jenkins D
    Methods Mol Med; 2005; 119():61-72. PubMed ID: 16350397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
    Guo M; Khanna A; Wang J; Dawlett MA; Kologinczak TL; Lyons GR; Bassett RL; Sneige N; Gong Y; Bevers TB
    Cancer Cytopathol; 2017 Aug; 125(8):644-651. PubMed ID: 28498639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
    Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
    Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cervical neoplasia in the patient with HIV infection.
    Stratton P; Ciacco KH
    Curr Opin Obstet Gynecol; 1994 Feb; 6(1):86-91. PubMed ID: 8180357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.
    Sellors JW; Lorincz AT; Mahony JB; Mielzynska I; Lytwyn A; Roth P; Howard M; Chong S; Daya D; Chapman W; Chernesky M
    CMAJ; 2000 Sep; 163(5):513-8. PubMed ID: 11006761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.